Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene in the treatment of schizophrenia
IRCT201205131556N42Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of raloxifene in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Jun 2012; status: completed.
02
Drugs
raloxifene
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201205131556N42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201205131556N42.